A causal model for joint evaluation of placebo and treatment-specific effects in clinical trials

Biometrics

Volumn 69, Issue 2, 2013, Pages 318-327

  Zhang, Zhiwei ^a   Kotz, Richard M ^a   Wang, Chenguang ^b   Ruan, Shiling ^a   Ho, Martin ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Blinding; Causal inference; Confounding; Counterfactual; Placebo effect; Potential outcome

Indexed keywords

PATIENT TREATMENT;

BLINDING; CAUSAL INFERENCES; CAUSAL MODELING; CLINICAL TRIAL; CONFOUNDING; COUNTERFACTUALS; MEDICAL TREATMENT; PLACEBO EFFECTS; POTENTIAL OUTCOMES; SPECIFIC EFFECTS;

MEDICAL APPLICATIONS;

ANALYTICAL METHOD; ASTHMA; DATA PROCESSING; DISEASE TREATMENT; MEDICINE; NUMERICAL MODEL; PERCEPTION; PROBABILITY;

EID: 84879603889     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/biom.12005     Document Type: Article

References (28)

1. Bang, H., Flaherty, S. P., Kolahi, J., and Park, J. (2010). Blinding assessment in clinical trials: A review of statistical methods and a proposal of blinding assessment protocol. Clinical Research and Regulatory Affairs 27, 42-51.
2. Bang, H., Ni, L., and Davis, C. E. (2004). Assessment of blinding in clinical trials. Controlled Clinical Trials 25, 143-156.
3. Bang, H., and Robins, J. M. (2005). Doubly robust estimation in missing data and causal inference models. Biometrics 61, 962-972.
4. Brinjikji, W., Comstock, B. A., Heagerty, P. J., Jarvik, J. G., and Kallmes, D. F. (2010). Investigational vertebroplasty efficacy and safety trial: Detailed analysis of blinding efficacy. Radiology 257, 219-225.
5. Brumback, B. A., Hernan, M. A., Haneuse, S. J., and Robins, J. M. (2004). Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Statistics in Medicine 23, 749-767.
6. Eickhoff, J. C. (2008). Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials. Statistics in Medicine 27, 1387-1402.
7. Fuller, R. K., Williford, W. O., William, O., Lee, K. K., and Derman, R. (1984). Veterans Administration cooperative study of disulfiram for the treatment of alcoholism: Study design and methodological considerations. Controlled Clinical Trials 5, 263-273.
8. Horvitz, D. G., and Thompson, D. J. (1952). A generalization of sampling without replacement from a finite universe. Journal of the American Statistical Association 47, 663-685.
9. Imai, K. and van Dyk, D. A. (2004). Causal inference with general treatment regimes: Generalizing the propensity score. Journal of the American Statistical Association 99, 854-866.
10. James, K. E., Bloch, D. A., Lee, K. K., Kraemer, H. C., and Fuller, R. K. (1996). An index for assessing blindness in a multi-centre clinical trial: Disulfiram for alcohol cessation-a VA cooperative study. Statistics in Medicine 15, 1421-1434.
11. Lin, D. Y., Psaty, B. M., and Kronmal, R. A. (1998). Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 54, 948-963.
12. Moore, K. L., Neugebauer, R., van der Laan, M. J., and Tager, I. B. (2012). Causal inference in epidemiological studies with strong confounding. Statistics in Medicine 31, 1380-1404.
13. Owen, A. B. (2001). Empirical likelihood. Boca Raton, FL: Chapman & Hall.
14. Qin, J. and Lawless, J. (1994). Empirical likelihood and general estimating equations. Annals of Statistics 22, 300-325.
15. Robins, J. M. and Greenland, S. (1992). Identifiability and exchangeability for direct and indirect effects. Epidemiology 3, 143-155.
16. Robins, J. M., Hernan, M. A., and Brumback, B. (2000). Marginal structural models and causal inference in epidemiology. Epidemiology 11, 550-560.
17. Robins, J. M., Rotnitzky, A., and Zhao, L. P. (1994). Estimation of regression coefficients when some regressors are not always observed. Journal of the American Statistical Association 89, 846-866.
18. Rosenbaum, P. R. and Rubin, D. B. (1983a). The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41-55.
19. Rosenbaum, P. R. and Rubin, D. B. (1983b). Assessing sensitivity to an unobserved binary covariate in an observational study with binary outcome. Journal of the Royal Statistical Society, Series B 45, 212-218.
20. Rubin, D. B. (1974). Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology 66, 688-701.
21. Rubin, D. B. (1976). Inference and missing data. Biometrika 63, 581-592.
22. Rubin, D. B. (2004). Direct and indirect causal effects via potential outcomes. Sandinavian Journal of Statistics 31, 161-170.
23. Tan, Z. (2010). Bounded, efficient and doubly robust estimation with inverse weighting. Biometrika 97, 661-682.
24. Turner, J. A., Jensen, M. P., Warms, C. A., and Cardenas, D. D. (2002). Blinding effectiveness and association of pertreatment expectations with pain improvement in a double-blind randomized controlled trial. Pain 99, 91-99.
25. van der Laan, M. J. and Robins, J. M. (2003). Unified Methods for Censored Longitudinal Data and Causality. New York: Spring-Verlag.
26. van der Laan, M. J. and Rubin, D. B. (2006). Targeted maximum likelihood learning. The International Journal of Biostatistics 2(1), Article 11. doi: 10.2202/1557-4679.1043.
27. VanderWeele, T. J. (2008). Simple relations between principal stratification and direct and indirect effects. Statistics and Probability Letters 78, 2957-2962.
28. Zhang, Z., Zhou, J., Cao, W., and Zhang, J. (2012). Causal inference with a quantitative exposure. Statistical Methods in Medical Research, in press.